Clinical trials
Muscular Dystrophy, Duchenne trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NS Pharma, Inc. | 3 |
| Peking Union Medical College Hospital | 3 |
| Kyntra Bio | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| General Hospital of Chinese Armed Police Forces | 1 |
| HuidaGene Therapeutics Co., Ltd. | 1 |
| Ning Wang, MD., PhD. | 1 |
| PTC Therapeutics | 1 |
| Pfizer | 1 |
| Shanghai Siponuoyin Biotechnology Co Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophy, Duchenne | 19 |
| Muscular Dystrophies | 4 |
| Genetic Diseases, Inborn | 2 |
| Genetic Diseases, X-Linked | 2 |
| Muscular Diseases | 2 |
| Muscular Disorders, Atrophic | 2 |
| Musculoskeletal Diseases | 2 |
| Nervous System Diseases | 2 |
| Neuromuscular Diseases | 2 |
| Cardiomyopathies | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.